Literature DB >> 22911661

Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells.

Elizabeth C Martin1, Steven Elliott, Lyndsay V Rhodes, James W Antoon, Claire Fewell, Yun Zhu, Jennifer L Driver, Mona Jodari-Karimi, Christopher W Taylor, Erik K Flemington, Barbara S Beckman, Bridgette M Collins-Burow, Matthew E Burow.   

Abstract

microRNAs (miRNA) are regulators of cellular pathways and alterations of normal miRNA expression levels have been shown to increase tumorigenesis. miR-24 has been demonstrated as having both tumor suppressive and oncogenic properties depending on cell context. Here, we demonstrate a possible role for pre-miR-24-2 as a tumor suppressor in the MCF-7 breast cancer cell line through the preferential processing of mature miR-24-2* over miR-24. Specifically, we show that the ectopic expression of miR-24-2* in MCF-7 breast cancer cells results in a suppression of cellular survival both in vivo and in vitro. Notably, the overexpression of miR-24-2* results in a dampening of cell survival through the targeted suppression of PKCα. In addition, a similar biological change is observed in vivo where MCF-7 cells overexpressing pre-miR-24-2 have decreased tumorigenicity and tumor incidence. Taken together our data demonstrate that when overexpressed biogenesis of the pre-miR-24-2 favors miR-24-2* in the MCF-7 breast cancer cell line and suggests a tumor suppressive role for miR-24-2* observed through the inhibition of PKCα-mediated cellular survival.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  PKCα cellular survival; breast cancer; miR-24-2*; miRNA maturation; strand preference

Mesh:

Substances:

Year:  2012        PMID: 22911661      PMCID: PMC4030540          DOI: 10.1002/mc.21946

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  53 in total

Review 1.  MicroRNA functions in animal development and human disease.

Authors:  Ines Alvarez-Garcia; Eric A Miska
Journal:  Development       Date:  2005-11       Impact factor: 6.868

2.  MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.

Authors:  Merav Bar; Stacia K Wyman; Brian R Fritz; Junlin Qi; Kavita S Garg; Rachael K Parkin; Evan M Kroh; Ausra Bendoraite; Patrick S Mitchell; Angelique M Nelson; Walter L Ruzzo; Carol Ware; Jerald P Radich; Robert Gentleman; Hannele Ruohola-Baker; Muneesh Tewari
Journal:  Stem Cells       Date:  2008-06-26       Impact factor: 6.277

Review 3.  Protein kinase C: structure, function, and regulation.

Authors:  A C Newton
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

4.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

5.  Ets1 is an effector of protein kinase Calpha in cancer cells.

Authors:  Martina Vetter; Sibylle G Blumenthal; Ralph K Lindemann; Joachim Manns; Sebastian Wesselborg; Christoph Thomssen; Jürgen Dittmer
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

6.  PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling.

Authors:  Christopher B Weldon; Amy McKee; Bridgette M Collins-Burow; Lilia I Melnik; Aline B Scandurro; John A McLachlan; Matthew E Burow; Barbara S Beckman
Journal:  Int J Oncol       Date:  2005-03       Impact factor: 5.650

7.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.

Authors:  D K Ways; C A Kukoly; J deVente; J L Hooker; W O Bryant; K J Posekany; D J Fletcher; P P Cook; P J Parker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  p16(INK4a) translation suppressed by miR-24.

Authors:  Ashish Lal; Hyeon Ho Kim; Kotb Abdelmohsen; Yuki Kuwano; Rudolf Pullmann; Subramanya Srikantan; Ramesh Subrahmanyam; Jennifer L Martindale; Xiaoling Yang; Fariyal Ahmed; Francisco Navarro; Derek Dykxhoorn; Judy Lieberman; Myriam Gorospe
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

9.  Alternative isoform regulation in human tissue transcriptomes.

Authors:  Eric T Wang; Rickard Sandberg; Shujun Luo; Irina Khrebtukova; Lu Zhang; Christine Mayr; Stephen F Kingsmore; Gary P Schroth; Christopher B Burge
Journal:  Nature       Date:  2008-11-27       Impact factor: 49.962

10.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.

Authors:  Cherie Blenkiron; Leonard D Goldstein; Natalie P Thorne; Inmaculada Spiteri; Suet-Feung Chin; Mark J Dunning; Nuno L Barbosa-Morais; Andrew E Teschendorff; Andrew R Green; Ian O Ellis; Simon Tavaré; Carlos Caldas; Eric A Miska
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  25 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

2.  MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.

Authors:  Elizabeth C Martin; Adrienne K Conger; Thomas J Yan; Van T Hoang; David F B Miller; Aaron Buechlein; Douglas B Rusch; Kenneth P Nephew; Bridgette M Collins-Burow; Matthew E Burow
Journal:  FEBS Lett       Date:  2017-01-12       Impact factor: 4.124

3.  Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation.

Authors:  E C Martin; A T Qureshi; C B Llamas; M E Burow; A G King; O C Lee; V Dasa; M A Freitas; J A Forsberg; E A Elster; T A Davis; J M Gimble
Journal:  Adipocyte       Date:  2018-02-07       Impact factor: 4.534

4.  miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.

Authors:  Liyan Wang; Xiaonan Li; Wei Zhang; Yuxin Yang; Qiuyu Meng; Chen Wang; Xiaoru Xin; Xiaoxue Jiang; Shuting Song; Yanan Lu; Hu Pu; Xin Gui; Tianming Li; Jie Xu; Jiao Li; Song Jia; Dongdong Lu
Journal:  Mol Ther       Date:  2019-10-24       Impact factor: 11.454

5.  Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.

Authors:  Yang Gao; Yimin Liu; Lutao Du; Juan Li; Ailin Qu; Xin Zhang; Lili Wang; Chuanxin Wang
Journal:  Med Oncol       Date:  2014-12-13       Impact factor: 3.064

Review 6.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

7.  Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.

Authors:  William J Magner; Bianca Weinstock-Guttman; Mina Rho; David Hojnacki; Rabia Ghazi; Murali Ramanathan; Thomas B Tomasi
Journal:  J Neuroimmunol       Date:  2016-01-21       Impact factor: 3.478

8.  Involvement of microRNAs in infection of silkworm with bombyx mori cytoplasmic polyhedrosis virus (BmCPV).

Authors:  Ping Wu; Shaohua Han; Tao Chen; Guangxing Qin; Long Li; Xijie Guo
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Shifts in temperature within the physiologic range modify strand-specific expression of select human microRNAs.

Authors:  Ratnakar Potla; Ishwar S Singh; Sergei P Atamas; Jeffrey D Hasday
Journal:  RNA       Date:  2015-05-27       Impact factor: 4.942

10.  Regulation of TRIB3 mRNA and protein in breast cancer.

Authors:  Marloes Wennemers; Johan Bussink; Twan van den Beucken; Fred C G J Sweep; Paul N Span
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.